• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical Significance and Role of TK1, CEA, CA 19-9 and CA 72-4 levels in Diagnosis of Colorectal Cancers.TK1、CEA、CA19-9 和 CA72-4 水平在结直肠癌诊断中的临床意义及作用。
Asian Pac J Cancer Prev. 2020 Nov 1;21(11):3133-3136. doi: 10.31557/APJCP.2020.21.11.3133.
2
Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients.血清胸苷激酶1、癌胚抗原、糖类抗原19-9和糖类抗原72-4水平在胃癌和结直肠癌患者中的临床意义及诊断能力
J Cancer. 2018 Jan 1;9(3):494-501. doi: 10.7150/jca.21562. eCollection 2018.
3
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.评估血清 CEA、CA19-9、CA72-4、CA125 和铁蛋白作为结直肠癌的诊断标志物和临床参数的影响因素。
Sci Rep. 2018 Feb 9;8(1):2732. doi: 10.1038/s41598-018-21048-y.
4
Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.癌胚抗原和癌抗原19-9对结直肠癌的诊断价值。
Int J Clin Exp Pathol. 2015 Aug 1;8(8):9404-9. eCollection 2015.
5
Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer Biomarkers in Colorectal Cancer.血清细胞角蛋白、胸苷激酶和生长因子在结直肠癌中的评估作为癌症生物标志物。
Anticancer Res. 2024 Jul;44(7):3105-3113. doi: 10.21873/anticanres.17124.
6
Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.血清癌胚抗原、糖类抗原72-4、糖类抗原19-9及肿瘤特异性生长因子联合检测在胃癌诊断中的价值
Asian Pac J Cancer Prev. 2015;16(9):3867-70. doi: 10.7314/apjcp.2015.16.9.3867.
7
Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.术前血清癌胚抗原(CEA)、糖类抗原19-9(CA19-9)和糖类抗原242(CA242)联合检测可改善接受手术治疗的结直肠癌患者的预后预测。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):14853-63. eCollection 2015.
8
Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer.血清骨膜蛋白作为结直肠癌潜在诊断和预后标志物的鉴定
Clin Lab. 2018 Jun 1;64(6):973-981. doi: 10.7754/Clin.Lab.2018.171225.
9
Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.胃癌患者中CA72-4与CEA和CA19-9相比的临床意义及预后价值
Dis Markers. 2000;16(3-4):105-10. doi: 10.1155/2000/595492.
10
Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer.血清癌胚抗原、糖类抗原19-9及糖类抗原72-4在胃癌患者中的临床意义及诊断价值
Oncotarget. 2016 Aug 2;7(31):49565-49573. doi: 10.18632/oncotarget.10391.

引用本文的文献

1
Kiperin Double-Hydrolyzed Collagen as a Potential Anti-Tumor Agent: Effects on HCT116 Colon Carcinoma Cells and Oxidative Stress Modulation.凯普瑞宁双水解胶原蛋白作为一种潜在的抗肿瘤药物:对HCT116结肠癌细胞的影响及氧化应激调节
Curr Issues Mol Biol. 2025 May 15;47(5):364. doi: 10.3390/cimb47050364.
2
Thymidine Kinase 1 Expression Correlates with Tumor Aggressiveness and Metastatic Potential in OSCC.胸苷激酶1表达与口腔鳞状细胞癌的肿瘤侵袭性和转移潜能相关。
Diagnostics (Basel). 2025 Jun 19;15(12):1567. doi: 10.3390/diagnostics15121567.
3
Alterations in expression of miRNA 497 and long non-coding RNAS (XIST-TSIX) and its significant role in colorectal cancer prediction.微小RNA 497和长链非编码核糖核酸(XIST-TSIX)表达的改变及其在结直肠癌预测中的重要作用。
Sci Rep. 2025 Mar 3;15(1):7387. doi: 10.1038/s41598-025-90110-3.
4
Relationship between clinical features and distant metastases in rectal cancer predicted based on a nomogram: a retrospective cohort study.基于列线图预测的直肠癌临床特征与远处转移的关系:一项回顾性队列研究
Sci Rep. 2024 Dec 28;14(1):31219. doi: 10.1038/s41598-024-82595-1.
5
The diagnostic value of serum Ephrin-A1 in patients with colorectal cancer.血清Ephrin-A1在结直肠癌患者中的诊断价值。
Sci Rep. 2024 Dec 28;14(1):31194. doi: 10.1038/s41598-024-82540-2.
6
GLR in Colorectal Cancers: An Easily Accessible Prognostic Marker.结直肠癌中的谷氨酸受体:一种易于获取的预后标志物。
Int J Gen Med. 2024 May 22;17:2361-2369. doi: 10.2147/IJGM.S463769. eCollection 2024.
7
(Sialyl)Lewis Antigen Expression on Glycosphingolipids, N-, and O-Glycans in Colorectal Cancer Cell Lines is Linked to a Colon-Like Differentiation Program.(唾液酸)Lewis 抗原在结直肠癌细胞系糖脂、N-和 O-聚糖上的表达与结肠样分化程序相关。
Mol Cell Proteomics. 2024 Jun;23(6):100776. doi: 10.1016/j.mcpro.2024.100776. Epub 2024 Apr 25.
8
Preoperative albumin-to-globulin ratio and prognostic nutritional index predict the prognosis of colorectal cancer: a retrospective study.术前白蛋白与球蛋白比值及预后营养指数预测结直肠癌预后:一项回顾性研究。
Sci Rep. 2023 Oct 12;13(1):17272. doi: 10.1038/s41598-023-43391-5.
9
Systematic analyzing a five- miRNA panel and its diagnostic value of plasma expression in colorectal cancer.系统分析五个 miRNA 标志物在结直肠癌患者血浆中的表达及其诊断价值。
Mol Biol Rep. 2023 Sep;50(9):7253-7261. doi: 10.1007/s11033-023-08642-8. Epub 2023 Jul 7.
10
In-Depth Analysis of the -Glycome of Colorectal Cancer Cell Lines.深入分析结直肠癌细胞系的 - 聚糖组。
Int J Mol Sci. 2023 Mar 2;24(5):4842. doi: 10.3390/ijms24054842.

本文引用的文献

1
A meta-analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment.血清胸腺嘧啶激酶1作为结直肠良恶性肿瘤风险评估标志物的荟萃分析。
Mol Clin Oncol. 2020 May;12(5):440-450. doi: 10.3892/mco.2020.2002. Epub 2020 Feb 25.
2
Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies.胸苷激酶1的膜表达及其在肺癌、乳腺癌和结直肠癌中的潜在临床意义。
Cancer Cell Int. 2018 Sep 10;18:135. doi: 10.1186/s12935-018-0633-9. eCollection 2018.
3
Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients.血清胸苷激酶1、癌胚抗原、糖类抗原19-9和糖类抗原72-4水平在胃癌和结直肠癌患者中的临床意义及诊断能力
J Cancer. 2018 Jan 1;9(3):494-501. doi: 10.7150/jca.21562. eCollection 2018.
4
Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.CEA、CA19-9、AFP 和 CA125 对早期胃癌的诊断和预后价值。
BMC Cancer. 2017 Nov 9;17(1):737. doi: 10.1186/s12885-017-3738-y.
5
Expression and Clinical Significance of Cytokeratin-19 and Thymidine Kinase-1 in Advanced Gastrointestinal Cancer.细胞角蛋白-19和胸苷激酶-1在进展期胃肠道癌中的表达及临床意义
Chin Med J (Engl). 2016 Sep 20;129(18):2168-72. doi: 10.4103/0366-6999.189919.
6
Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer.血清癌胚抗原、糖类抗原19-9及糖类抗原72-4在胃癌患者中的临床意义及诊断价值
Oncotarget. 2016 Aug 2;7(31):49565-49573. doi: 10.18632/oncotarget.10391.
7
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
8
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).1995 - 2009年全球癌症生存情况监测:对来自67个国家279个基于人群的登记处的25,676,887例患者的个体数据进行分析(CONCORD - 2)
Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26.
9
Serum thymidine kinase 1 activity in solid tumor (breast and colorectal cancer) patients treated with adjuvant chemotherapy.辅助化疗治疗的实体瘤(乳腺癌和结直肠癌)患者血清胸苷激酶 1 活性。
J Clin Lab Anal. 2013 May;27(3):220-6. doi: 10.1002/jcla.21587.
10
Current status of screening for colorectal cancer.结直肠癌筛查的现状。
Ann Oncol. 2013 Aug;24(8):1963-72. doi: 10.1093/annonc/mdt157. Epub 2013 Apr 25.

TK1、CEA、CA19-9 和 CA72-4 水平在结直肠癌诊断中的临床意义及作用。

Clinical Significance and Role of TK1, CEA, CA 19-9 and CA 72-4 levels in Diagnosis of Colorectal Cancers.

机构信息

Department of Biochemistry, Netaji Subhas Medical College and Hospital, Patna, India.

Department of Surgical Gastroenterology and Liver Transplant, Indira Gandhi Institute of Medical Sciences, Patna, India.

出版信息

Asian Pac J Cancer Prev. 2020 Nov 1;21(11):3133-3136. doi: 10.31557/APJCP.2020.21.11.3133.

DOI:10.31557/APJCP.2020.21.11.3133
PMID:33247667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8033132/
Abstract

To explore the diagnostic value, pre-operative serum thymidine kinase 1(TK1), CEA, CA 19-9 and CA 72-4 levels were measured in 106 patients with colorectal carcinoma (53 colon and 53 rectal carcinoma patients) and 53 healthy controls. Sandwich Elisa, biotin-labeled antibody kit was used for TK1, and other tumor markers were measured using electro-chemiluminescence. Serum TK1 levels were significantly higher in CRC than in healthy controls (p <0.05) and showed significant associations with tumor stage, histopathological grade, lymph node status and metastasis (p <0.01). TK1 showed the highest (0.824-0.862) area under receiver operating characteristics curve (AUC) in comparison to other markers, and the AUC of the panel of combination tests performed even better (0.935-0.952). Significant variation was observed between the single biomarker test and their combination (Z test, p <0.01) and the Hosmer-Lemeshow test showed an adequate model of calibration. The algorithm based on combination of TK1, CEA, CA19-9 and CA72-4 can improve the diagnostic efficiency in CRC patients.
.

摘要

为了探索诊断价值,我们测量了 106 例结直肠癌患者(53 例结肠癌和 53 例直肠癌患者)和 53 例健康对照者术前血清胸苷激酶 1(TK1)、CEA、CA19-9 和 CA72-4 水平。采用夹心 ELISA、生物素标记抗体试剂盒检测 TK1,其他肿瘤标志物采用电化学发光法检测。CRC 患者血清 TK1 水平明显高于健康对照组(p<0.05),且与肿瘤分期、组织病理学分级、淋巴结状态和转移显著相关(p<0.01)。与其他标志物相比,TK1 的受试者工作特征曲线下面积(AUC)最高(0.824-0.862),联合检测的 AUC 甚至更好(0.935-0.952)。单项生物标志物检测与其组合之间存在显著差异(Z 检验,p<0.01),Hosmer-Lemeshow 检验显示校准模型适当。基于 TK1、CEA、CA19-9 和 CA72-4 联合的算法可以提高 CRC 患者的诊断效率。